Home

Jagsonpal Pharmaceuticals PE Ratio

Image

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM

PE

35.1

Last updated on: May 09, 2025

Key Highlights

  • The P/E Ratio of Jagsonpal Pharmaceuticals Ltd is 35.1 as of 09 May 10:56 AM .
  • The P/E Ratio of Jagsonpal Pharmaceuticals Ltd changed from 5.8 on March 2020 to 32.9 on March 2024 . This represents a CAGR of 41.50% over 5 years.
  • The Latest Trading Price of Jagsonpal Pharmaceuticals Ltd is ₹ 205.25 as of 09 May 10:49 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.1 to 40.1 in 5 years. This represents a CAGR of 13.70%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 40.1. The PE Ratio of Retail industry is 139.8. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Jagsonpal Pharmaceuticals Ltd

No data available

Company Fundamentals for Jagsonpal Pharmaceuticals Ltd

Image

Jagsonpal Pharmaceuticals Ltd

NSE: JAGSNPHARM

Share Price

₹ 205.25

-4.75 (-2.26%)

stock direction

Last updated on: May 09, 2025

Market Price of Jagsonpal Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Jagsonpal Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
08 May 2025210
07 May 2025220.1
06 May 2025238.95
05 May 2025250.05
02 May 2025235.6
30 Apr 2025225.2
29 Apr 2025227.3
28 Apr 2025232.5
25 Apr 2025243.55
24 Apr 2025239.2

SWOT Analysis Of Jagsonpal Pharmaceuticals Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Jagsonpal Pharmaceuticals Ltd

Asset Value vs Market Value of Jagsonpal Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Jagsonpal Pharmaceuticals Ltd1394
Sun Pharmaceutical Industries Ltd423771
Divis Laboratories Ltd158175
Cipla Ltd120076
Torrent Pharmaceuticals Ltd107722
Mankind Pharma Ltd100426

PE Ratio of Jagsonpal Pharmaceuticals Ltd Explained

1394

Market cap

55

Earnings

35.1X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Jagsonpal Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Jagsonpal Pharmaceuticals Ltd

No data available

* All values are in %

About Jagsonpal Pharmaceuticals Ltd

  • Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
  • The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
  • Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
  • It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
  • In 1994, the company has also promoted Aresco Financial Services, a new financial company.

Jagsonpal Pharmaceuticals Ltd News Hub

Jagsonpal Pharmaceuticals AGM scheduled

Jagsonpal Pharmaceuticals announced that the 45th Annual General Meeting (AGM) of the company will b

Read more

13 Aug 24

Jagsonpal Pharmaceuticals standalone net profit declines 28.74% in the June 2024 quarter

Net profit of Jagsonpal Pharmaceuticals declined 28.74% to Rs 5.33 crore in the quarter ended June 2

Read more

08 Aug 24

Jagsonpal Pharmaceuticals declare Quarterly Result

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 August 2

Read more

01 Aug 24

Jagsonpal Pharmaceuticals to table results

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 23 October

Read more

17 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Jagsonpal Pharmaceuticals Ltd

What is the current PE Ratio of Jagsonpal Pharmaceuticals Ltd?

The Current PE Ratio of Jagsonpal Pharmaceuticals Ltd is 35.06 as on 9 May 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.1 as on 9 May 2025.

What was the PE Ratio of Jagsonpal Pharmaceuticals Ltd last year?

The PE Ratio of Jagsonpal Pharmaceuticals Ltd was 28.42 last year, now the PE ratio is 35.06, showing a year-on-year growth of 23.4%.

What does the PE Ratio of Jagsonpal Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Jagsonpal Pharmaceuticals Ltd is 35.06. This ratio indicates that investors are willing to pay 35.06 times the earnings per share for each share of Jagsonpal Pharmaceuticals Ltd.

What is the PE Ratio Growth of Jagsonpal Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Jagsonpal Pharmaceuticals Ltd grew by 23.4% whereas, the EPS ratio grew by -79.3.

How does the PE ratio of Jagsonpal Pharmaceuticals Ltd compare to industry peers?

The PE ratio of Jagsonpal Pharmaceuticals Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Jagsonpal Pharmaceuticals Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Jagsonpal Pharmaceuticals Ltd PE Ratio.

What factors influence the PE ratio of Jagsonpal Pharmaceuticals Ltd PE Ratio?

The PE ratio of Jagsonpal Pharmaceuticals Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Jagsonpal Pharmaceuticals Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Jagsonpal Pharmaceuticals Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Jagsonpal Pharmaceuticals Ltd PE Ratio?

You can check the latest PE ratio of Jagsonpal Pharmaceuticals Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Jagsonpal Pharmaceuticals Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Jagsonpal Pharmaceuticals Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Jagsonpal Pharmaceuticals Ltd PE Ratio predict future stock performance?

While the Jagsonpal Pharmaceuticals Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions